2 2021 Annual Conference | Thrombosis Canada – Thrombose Canada
Go to Top

2021 Annual Conference

 

 

 

 

 

SCIENTIFIC PLANNING COMMITTEE

Co-chairs
Lana Castellucci Hematology; Co-chair MD, FRCPC, MSc
Eric Tseng Hematology; Co-chair MD, MScCH, FRCPC
Committee Members:
Jameel Abdulrehman Hematology MD, FRCPC
Julia Bayadinova NP, Thrombosis NP-PHC, MN
Ania Bekasiak Family Medicine MD
Leonardo Brandão Pediatric hematology MD
Timothy Chan Internal Medicine MD, FRCPC
Tamer Elias Pharmacist PharmD, BCGP, RPh
Karen Moffat Coagulation Lab BEd, MSc, ART, FCSMLS(D)
Joseph Shaw Hematology Fellow MD, FRCPC

OVERALL MEETING OBJECTIVES

After completing this program, participants will be equipped to:

  • Apply current evidence in the management of patients with thrombotic disease
  • Manage thrombosis challenges in face-to-face and virtual clinical practice effectively
  • Describe thrombosis prophylaxis and treatment in patients affected by COVID-19
  • Implement thrombosis treatment options in a variety of patient populations

ACCREDITATION

Breakfast Symposium:

This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter
for up to 1.00 Mainpro+ credits.

Main Conference:

This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 5.50  Mainpro+ credits.

Breakfast symposium and main conference combined:

  The Canadian Council on Continuing Education in Pharmacy has accredited this program for 11.75 CEUs.
Le Conseil canadien de l’éducation continue en pharmacie a octroyé 11.75 crédits de formation continue pour ce programme.

Main Conference:

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Ottawa’s Office of Continuing Professional Development. You may claim a maximum of 5.5 hours (credits are automatically calculated).

AGENDA

Time Topic Speakers
7:30 – 8:30 Sponsored Breakfast Symposium:
Cancer-associated thrombosis: What’s new?
Marc Carrier
Vicky Tagalakis
Jeff Habert
Cynthia Wu
8:45 – 9:00 Conference opening remarks Lana Castellucci
Eric Tseng
9:00 – 9:30 Hormones and the transgender patient Jean Connors
9:30 – 10:00 DOACs in adolescents Leonardo Brandão
10:00 – 10:30 Management of anticoagulant-associated heavy menstrual bleeding Joseph Shaw
10:30 – 10:45 BREAK
10:45 – 11:15 Antithrombotics and stroke Thalia Field
11:15 – 11:45 Core labs and anticoagulant use Karen Moffat
11:45 – 12:15 Virtual care and thrombosis management: A new era Timothy Chan
12:15 – 13:15 LUNCH 
13:15 – 13:45 Covid: Anticoagulation in hospitalized patients Vicky Tagalakis
13:45 – 14:15 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following adenoviral vector COVID-19vaccines: What have we learned? Menaka Pai
14:15 – 14:30 BREAK                                                                                        Facilitators                     
Each workshop is run twice:

 

14:30 – 15:15

and

15:15 – 16:00

Pediatric thrombosis Leonardo Brandão
Mihir Bhatt
Extended VTE prophylaxis: post-hospitalization and post unprovoked VTE Peter Gross
Rick Ikesaka
Unusual site VTE: splanchnic vein, retinal vein, cerebral vein, others Zach Liederman
Alejandro Lazo-Langner
ASA for primary prevention and PAD Alan Bell
Vera Dounaevskaia
Bleeding management and resuming anticoagulation; tricky INRs Rita Selby
Deb Siegal
Perioperative management Joseph Shaw
Julia Bayadinova
Women’s health/pregnancy/VTE Isabelle Malhamé
Special populations; elderly, obese, CKD, renal Timothy Chan
Jameel Abdulrehman
Emergency management of VTE in the ED Kerstin de Wit
Lana Castellucci

Click here for more information and to register to attend: 2021 Conference Registration

This program is supported by educational grants from Alexion AstraZeneca Rare Diseases, Bayer Inc., BMS-Pfizer, LEO Pharma, Pfizer Hospital, Sanofi, Servier Canada and Valeo Canada